CapForce IBD 50 ETF
FFTY
70 hedge funds and large institutions have $91.9M invested in CapForce IBD 50 ETF in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 21 increasing their positions, 27 reducing their positions, and 18 closing their positions.
0.93% less ownership
Funds ownership: 28.01% → 27.08% (-0.93%)
16% less funds holding
Funds holding: 83 → 70 (-13)
21% less capital invested
Capital invested by funds: $116M → $91.9M (-$24.4M)
22% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 27
72% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.59M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.19M |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$932K |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$686K |
| 5 |
Jane Street
New York
|
+$588K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$10.2M |
| 2 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$3.12M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.34M |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$957K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$953K |
FFTY Hedge Fund Activity: Q3 2019 in Review
70 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD 50 ETF (FFTY) for Q3 2019, worth a combined $91.9M — down 21% from $116M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of FFTY and 5 opened new positions — a net loss of 13 holders — while 27 trimmed existing stakes and 21 added.
The largest buyer was UBS Group, adding an estimated $1.59M. The largest seller was Wells Fargo, cutting an estimated $10.2M.
- 70 institutional investors held CapForce IBD 50 ETF (FFTY) as of Q3 2019, down from 83 in Q2 2019.
- Funds reported $91.9M of CapForce IBD 50 ETF stock for Q3 2019, down 21% quarter-over-quarter.
- 5 funds opened new CapForce IBD 50 ETF positions in Q3 2019 and 18 closed out, a net change of -13 holders.
- The largest CapForce IBD 50 ETF buyer in Q3 2019 was UBS Group, an estimated $1.59M added.
- The largest CapForce IBD 50 ETF seller in Q3 2019 was Wells Fargo, an estimated $10.2M sold.
Based on aggregated 13F filings for Q3 2019.